ADARx Pharmaceuticals, Inc. (ADRX) stock analysis
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.30−0.27 (-1.99%)
Close on Nov 11, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for ADARx Pharmaceuticals.
See a number that looks wrong?